Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 3.77% vs -14.91% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -0.07% vs 48.94% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 54.64% vs -23.90% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -2.38% vs 46.01% in Mar 2024
Compare Profit and Loss Results of Sudeep Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
477.00
-121.00
-25.37%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
477.00
-121.00
-25.37%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
6.00
-26.00
-433.33%
Raw Materials Consumed
146.00
114.00
32.00
28.07%
Power & Fuel Cost
7.00
17.00
-10.00
-58.82%
Employee Cost
26.00
99.00
-73.00
-73.74%
Operating Expenses
14.00
13.00
1.00
7.69%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
26.00
11.00
15.00
136.36%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
0.00
5.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
223.00
352.00
-129.00
-36.65%
Operating Profit (PBDIT) excl Other Income
132.00
124.00
8.00
6.45%
Other Income
8.00
83.00
-75.00
-90.36%
Operating Profit (PBDIT)
141.00
208.00
-67.00
-32.21%
Interest
5.00
6.00
-1.00
-16.67%
Profit before Depriciation and Tax
135.00
201.00
-66.00
-32.84%
Depreciation
6.00
48.00
-42.00
-87.50%
Profit Before Taxation & Exceptional Items
129.00
152.00
-23.00
-15.13%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
129.00
107.00
22.00
20.56%
Provision for Tax
33.00
37.00
-4.00
-10.81%
Profit After Tax
95.00
69.00
26.00
37.68%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
321.00
1,359.00
-1,038.00
-76.38%
Profit Available for appropriations
416.00
1,428.00
-1,012.00
-70.87%
Appropriations
416.00
1,428.00
-1,012.00
-70.87%
Equity Dividend (%)
0%
100%
-100.00
Earnings Per Share
8.82
7.16
1.66
23.18%
Profit And Loss - Net Sales
Net Sales 356.73 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.77% vs -14.91% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 132.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.07% vs 48.94% in Mar 2024
Profit And Loss - Interest
Interest 5.68 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 54.64% vs -23.90% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 95.75 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.38% vs 46.01% in Mar 2024
